{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:08:58Z","timestamp":1744258138282,"version":"3.40.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T00:00:00Z","timestamp":1549756800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T00:00:00Z","timestamp":1549756800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2019,4,3]]},"DOI":"10.1007\/s00705-019-04147-7","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T09:15:43Z","timestamp":1549790143000},"page":"1027-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Analysis of the efficacy of an adjuvant-based inactivated pandemic H5N1 influenza virus vaccine"],"prefix":"10.1007","volume":"164","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7039-5621","authenticated-orcid":false,"given":"Ainur","family":"Nurpeisova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markhabat","family":"Kassenov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nurkuisa","family":"Rametov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaissar","family":"Tabynov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gourapura J.","family":"Renukaradhya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yevgeniy","family":"Volgin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Altynay","family":"Sagymbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanzhol","family":"Makbuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abylay","family":"Sansyzbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Berik","family":"Khairullin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,10]]},"reference":[{"issue":"4","key":"4147_CR1","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3382\/ps.2008-00289","volume":"88","author":"I Capua","year":"2009","unstructured":"Capua I, Alexander DJ (2009) Avian influenza infection in birds: a challenge and opportunity for the poultry veterinarian. Poult Sci 88(4):842\u2013846. https:\/\/doi.org\/10.3382\/ps.2008-00289","journal-title":"Poult Sci"},{"issue":"13","key":"4147_CR2","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1056\/NEJMra052211","volume":"353","author":"JH Beigel","year":"2005","unstructured":"Beigel JH, Farrar J, Han AM et al (2005) Avian influenza A (H5N1) infection in humans. N Engl J Med 353(13):1374\u20131385. https:\/\/doi.org\/10.1056\/NEJMra052211","journal-title":"N Engl J Med"},{"key":"4147_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2005.04.018","volume":"23","author":"DM Fleming","year":"2005","unstructured":"Fleming DM, Elliot AJ (2005) The impact of influenza on the health and health care utilisation of elderly people. Vaccine 23:1\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2005.04.018","journal-title":"Vaccine"},{"key":"4147_CR4","unstructured":"World Health Organization (2016) Cumulative number of confirmed human cases of avian influenza A\/(H5N1) reported to WHO. http:\/\/www.who.int\/influenza\/human_animal_interface\/H5N1_cumulative_table_archives\/en\/. Accessed 20 June 2018"},{"key":"4147_CR5","unstructured":"Kydyrbaev ZhK, Tabynov KK, Khairullin BM (2015) Vysokopatogennyj gripp ptic: rasprostranenie v Kazahstane i razrabotka sredstv specificheskoj profilaktiki [Highly pathogenic avian influenza: distribution in Kazakhstan and development of means of specific prevention]. Almaty (in Russian)"},{"issue":"8","key":"4147_CR6","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1128\/CVI.00096-13","volume":"20","author":"AR Sansyzbay","year":"2013","unstructured":"Sansyzbay AR, Erofeeva MK, Khairullin BM et al (2013) Inactivated and adjuvanted whole virion clade 2.2 H5N1 (A\/chicken\/Astana\/6\/05) influenza vaccine is safe and immunogenic in a single dose in humans. Clin Vaccine Immunol 20(8):1314\u20131319. https:\/\/doi.org\/10.1128\/CVI.00096-13","journal-title":"Clin Vaccine Immunol"},{"issue":"1","key":"4147_CR7","first-page":"350","volume":"5","author":"M Stukova","year":"2011","unstructured":"Stukova M, Mamadaliyev S, Sandybayev N et al (2011) Basic results of development of a production technology and control of a pandemic influenza A\/H5N1 vaccine. Influenza Other Respir Viruses 5(1):350\u2013353","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"4147_CR8","first-page":"108","volume":"1","author":"A Nurpeysova","year":"2011","unstructured":"Nurpeysova A, Khairullin B, Kassenov M et al (2011) Preclinical testing of Kazfluvac\u00ae, a vaccine against pandemic influenza A\/H5N1v. J Pharm Biomed Sci 1(5):108\u2013112","journal-title":"J Pharm Biomed Sci"},{"issue":"11","key":"4147_CR9","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1086\/652701","volume":"201","author":"JM Langley","year":"2010","unstructured":"Langley JM, Frenette L, Ferguson L et al (2010) Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1\/2 trial in adults. J Infect Dis 201(11):1644\u20131653. https:\/\/doi.org\/10.1086\/652701","journal-title":"J Infect Dis"},{"issue":"8","key":"4147_CR10","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.4049\/jimmunol.178.8.5271","volume":"178","author":"H Li","year":"2007","unstructured":"Li H, Nookala S, Re F (2007) Aluminum hydroxide adjuvants activate caspase-1 and induce IL-1\u03b2 and IL-18 release. J Immunol 178(8):5271\u20135276. https:\/\/doi.org\/10.4049\/jimmunol.178.8.5271","journal-title":"J Immunol"},{"issue":"3","key":"4147_CR11","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/S0264-410X(96)00183-1","volume":"15","author":"JC Cox","year":"1997","unstructured":"Cox JC, Coulter AR (1997) Adjuvants\u2014a classification and review of their modes of action. Vaccine 15(3):248\u2013256. https:\/\/doi.org\/10.1016\/S0264-410X(96)00183-1","journal-title":"Vaccine"},{"issue":"21","key":"4147_CR12","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1056\/NEJMra1002842","volume":"363","author":"LC Lambert","year":"2010","unstructured":"Lambert LC, Fauci AS (2010) Influenza vaccines for the future. N Engl J Med 363(21):2036\u20132044. https:\/\/doi.org\/10.1056\/NEJMra1002842","journal-title":"N Engl J Med"},{"issue":"1","key":"4147_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.3390\/v2010166","volume":"2","author":"R Bodewes","year":"2010","unstructured":"Bodewes R, Osterhaus AD, Rimmelzwaan GF (2010) Targets for the induction of protective immunity against influenza a viruses. Viruses 2(1):166\u2013188. https:\/\/doi.org\/10.3390\/v2010166","journal-title":"Viruses"},{"issue":"13","key":"4147_CR14","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1056\/NEJMoa055778","volume":"354","author":"JJ Treanor","year":"2006","unstructured":"Treanor JJ, Campbell JD, Zangwill KM et al (2006) Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. N Engl J Med 354(13):1343\u20131351. https:\/\/doi.org\/10.1056\/NEJMoa055778","journal-title":"N Engl J Med"},{"issue":"2","key":"4147_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1086\/507544","volume":"194","author":"KL Nichol","year":"2006","unstructured":"Nichol KL, Treanor JJ (2006) Vaccines for seasonal and pandemic influenza. J Infect Dis 194(2):111\u2013118. https:\/\/doi.org\/10.1086\/507544","journal-title":"J Infect Dis"},{"issue":"1","key":"4147_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3201\/eid1201.051068","volume":"12","author":"AS Monto","year":"2006","unstructured":"Monto AS (2006) Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis 12(1):55. https:\/\/doi.org\/10.3201\/eid1201.051068","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"4147_CR17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cvex.2004.09.008","volume":"8","author":"I Langlois","year":"2005","unstructured":"Langlois I (2005) Viral diseases of ferrets. Vet Clin N Am Exot Anim Pract 8(1):139\u2013160. https:\/\/doi.org\/10.1016\/j.cvex.2004.09.008","journal-title":"Vet Clin N Am Exot Anim Pract"},{"issue":"5","key":"4147_CR18","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1242\/dmm.007823","volume":"4","author":"JA Belser","year":"2011","unstructured":"Belser JA, Katz JM, Tumpey TM (2011) The ferret as a model organism to study influenza A virus infection. Dis Model Mech 4(5):575\u2013579. https:\/\/doi.org\/10.1242\/dmm.007823","journal-title":"Dis Model Mech"},{"key":"4147_CR19","first-page":"25","volume-title":"Advanced laboratory techniques for influenza diagnosis. Immunology series no. 6. Part 2, procedural guide","author":"D Palmer","year":"1975","unstructured":"Palmer D, Dowdle W, Coleman M et al (1975) Advanced laboratory techniques for influenza diagnosis. Immunology series no. 6. Part 2, procedural guide. US Department of Health Education and Public Health Service, Atlanta, pp 25\u201362"},{"issue":"2","key":"4147_CR20","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0166-0934(80)90020-8","volume":"1","author":"J Huprikar","year":"1980","unstructured":"Huprikar J, Rabinowitz S (1980) A simplified plaque assay for influenza viruses in Madin\u2013Darby kidney (MDCK) cells. J Virol Methods 1(2):117\u2013120. https:\/\/doi.org\/10.1016\/0166-0934(80)90020-8","journal-title":"J Virol Methods"},{"issue":"2","key":"4147_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s10517-017-3964-y","volume":"164","author":"NN Asanzhanova","year":"2017","unstructured":"Asanzhanova NN, Ryskeldinova SZ, Chervyakova OV et al (2017) Comparison of different methods of purification and concentration in production of influenza vaccine. Bull Exp Biol Med 164(2):229\u2013232. https:\/\/doi.org\/10.1007\/s10517-017-3964-y","journal-title":"Bull Exp Biol Med"},{"issue":"23","key":"4147_CR22","doi-asserted-by":"publisher","first-page":"13037","DOI":"10.1128\/JVI.78.23.13037-13045.2004","volume":"78","author":"B Ferko","year":"2004","unstructured":"Ferko B, Stasakova J, Romanova J et al (2004) Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. J Virol 78(23):13037\u201313045. https:\/\/doi.org\/10.1128\/JVI.78.23.13037-13045.2004","journal-title":"J Virol"},{"issue":"9540","key":"4147_CR23","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1016\/S0140-6736(06)69294-5","volume":"368","author":"J Lin","year":"2006","unstructured":"Lin J, Zhang J, Dong X et al (2006) Safety and immunogenicity of an inactivated adjuvanted whole-virion influenza A (H5N1) vaccine: a phase I randomised controlled trial. Lancet 368(9540):991\u2013997. https:\/\/doi.org\/10.1016\/S0140-6736(06)69294-5","journal-title":"Lancet"},{"issue":"1","key":"4147_CR24","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3201\/eid1201.051147","volume":"12","author":"CJ Luke","year":"2006","unstructured":"Luke CJ, Subbaro K (2006) Vaccines for pandemic influenza. Emerg Infect Dis 12(1):66\u201372. https:\/\/doi.org\/10.3201\/eid1201.051147","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"4147_CR25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3201\/eid1201.051043","volume":"12","author":"P Palese","year":"2006","unstructured":"Palese P (2006) Making better influenza virus vaccines? Emerg Infect Dis 12(1):61\u201365. https:\/\/doi.org\/10.3201\/eid1201.051043","journal-title":"Emerg Infect Dis"},{"issue":"17","key":"4147_CR26","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1016\/j.vaccine.2005.07.005","volume":"24","author":"T Horimoto","year":"2006","unstructured":"Horimoto T, Takada A, Fujii K et al (2006) The development and characterization of H5 influenza virus vaccines derived from a 2003 human isolate. Vaccine 24(17):3669\u20133676. https:\/\/doi.org\/10.1016\/j.vaccine.2005.07.005","journal-title":"Vaccine"},{"issue":"5","key":"4147_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/mt.2016.23","volume":"24","author":"J De Jonge","year":"2016","unstructured":"De Jonge J, Isakova-Sivak I, Van Dijken H et al (2016) H7N9 live attenuated influenza vaccine is highly immunogenic, prevents virus replication, and protects against severe bronchopneumonia in ferrets. Mol Ther 24(5):991\u20131002. https:\/\/doi.org\/10.1038\/mt.2016.23","journal-title":"Mol Ther"},{"issue":"5","key":"4147_CR28","doi-asserted-by":"publisher","first-page":"01487-15","DOI":"10.1128\/mBio.01487-15","volume":"6","author":"M Baz","year":"2015","unstructured":"Baz M, Boonnak K, Paskel M et al (2015) Nonreplicating influenza A virus vaccines confer broad protection against lethal challenge. MBio 6(5):01487-15. https:\/\/doi.org\/10.1128\/mBio.01487-15","journal-title":"MBio"},{"issue":"4","key":"4147_CR29","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.vaccine.2015.12.023","volume":"34","author":"N Music","year":"2016","unstructured":"Music N, Reber AJ, Kim MC et al (2016) Supplementation of H1N1pdm09 split vaccine with heterologous tandem repeat M2e5x virus-like particles confers improved cross-protection in ferrets. Vaccine 34(4):466\u2013473. https:\/\/doi.org\/10.1016\/j.vaccine.2015.12.023","journal-title":"Vaccine"},{"issue":"15","key":"4147_CR30","doi-asserted-by":"publisher","first-page":"8591","DOI":"10.1128\/JVI.01081-13","volume":"87","author":"SF Baker","year":"2013","unstructured":"Baker SF, Guo H, Albrecht RA et al (2013) Protection against lethal influenza with a viral mimic. J Virol 87(15):8591\u20138605. https:\/\/doi.org\/10.1128\/JVI.01081-13","journal-title":"J Virol"},{"issue":"9","key":"4147_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/laban1004-50","volume":"33","author":"JA Maher","year":"2004","unstructured":"Maher JA, DeStefano J (2004) The ferret: an animal model to study influenza virus. Lab Anim (NY) 33(9):50\u201353. https:\/\/doi.org\/10.1038\/laban1004-50","journal-title":"Lab Anim (NY)"},{"issue":"19","key":"4147_CR32","doi-asserted-by":"publisher","first-page":"10366","DOI":"10.1128\/JVI.01035-10","volume":"84","author":"BJ Bosch","year":"2010","unstructured":"Bosch BJ, Bodewes R, de Vries RP et al (2010) Recombinant soluble, multimeric HA and NA exhibit distinctive types of protection against pandemic swine-origin 2009 A (H1N1) influenza virus infection in ferrets. J Virol 84(19):10366\u201310374. https:\/\/doi.org\/10.1128\/JVI.01035-10","journal-title":"J Virol"},{"issue":"8","key":"4147_CR33","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1086\/428951","volume":"191","author":"AS Lipatov","year":"2005","unstructured":"Lipatov AS, Webby RJ, Govorkova EA et al (2005) Efficacy of H5 influenza vaccines produced by reverse genetics in a lethal mouse model. J Infect Dis 191(8):1216\u20131220. https:\/\/doi.org\/10.1086\/428951","journal-title":"J Infect Dis"},{"issue":"41","key":"4147_CR34","doi-asserted-by":"crossref","first-page":"19361","DOI":"10.2807\/ese.14.41.19361-en","volume":"14","author":"K Johansen","year":"2009","unstructured":"Johansen K, Nicoll A, Ciancio BC et al (2009) Pandemic influenza A (H1N1) 2009 vaccines in the European Union. Euro Surveill 14(41):19361","journal-title":"Euro Surveill"},{"issue":"5","key":"4147_CR35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.5251\/abjna.2010.1.5.737.739","volume":"1","author":"MM Kassenov","year":"2010","unstructured":"Kassenov MM, Khairullin BM, Kydyrbayev ZhK et al (2010) Influenza monitoring among birds in Kostanaiskaya Oblast, Republic of Kazakhstan. Agric Biol J N Am 1(5):737\u2013739. https:\/\/doi.org\/10.5251\/abjna.2010.1.5.737.739","journal-title":"Agric Biol J N Am"},{"issue":"19","key":"4147_CR36","first-page":"521","volume":"58","author":"J Katz","year":"2009","unstructured":"Katz J, Hancock K, Veguilla V et al (2009) Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 58(19):521\u2013524","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"48","key":"4147_CR37","doi-asserted-by":"publisher","first-page":"6833","DOI":"10.1016\/j.vaccine.2012.09.013","volume":"30","author":"G Liu","year":"2012","unstructured":"Liu G, Song L, Reiserova L et al (2012) Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections. Vaccine 30(48):6833\u20136838. https:\/\/doi.org\/10.1016\/j.vaccine.2012.09.013","journal-title":"Vaccine"},{"issue":"18","key":"4147_CR38","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1016\/j.vaccine.2007.01.083","volume":"25","author":"A Ninomiya","year":"2007","unstructured":"Ninomiya A, Imai M, Tashiro M et al (2007) Inactivated influenza H5N1 whole-virus vaccine with aluminum adjuvant induces homologous and heterologous protective immunities against lethal challenge with highly pathogenic H5N1 avian influenza viruses in a mouse model. Vaccine 25(18):3554\u20133560. https:\/\/doi.org\/10.1016\/j.vaccine.2007.01.083","journal-title":"Vaccine"},{"issue":"26","key":"4147_CR39","doi-asserted-by":"publisher","first-page":"3209","DOI":"10.1016\/j.vaccine.2008.03.093","volume":"26","author":"V Schultze","year":"2008","unstructured":"Schultze V, D\u2019Agosto V, Wack A et al (2008) Safety of MF59\u2122 adjuvant. Vaccine 26(26):3209\u20133222. https:\/\/doi.org\/10.1016\/j.vaccine.2008.03.093","journal-title":"Vaccine"},{"issue":"6","key":"4147_CR40","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12250-012-3272-7","volume":"27","author":"K Tabynov","year":"2012","unstructured":"Tabynov K, Kydyrbayev Zh, Sansyzbay A et al (2012) Immunogenic and protective properties of the first kazakhstan vaccine against pandemic influenza A (H1N1) pdm09 in ferrets. Virol Sin 27(6):344\u2013351. https:\/\/doi.org\/10.1007\/s12250-012-3272-7","journal-title":"Virol Sin"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00705-019-04147-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-019-04147-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-019-04147-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:19:43Z","timestamp":1744175983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00705-019-04147-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,3]]}},"alternative-id":["4147"],"URL":"https:\/\/doi.org\/10.1007\/s00705-019-04147-7","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"type":"print","value":"0304-8608"},{"type":"electronic","value":"1432-8798"}],"subject":[],"published":{"date-parts":[[2019,2,10]]},"assertion":[{"value":"5 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}